Demonstrates targeted adsorption of various drugs in ingestions, suggesting improved clinical decisions for treatment.
This study supports the targeted use of activated charcoal in colchicine, hydroxychloroquine, ibuprofen, and strychnine ingestions. Isotherm modeling reveals xenobiotic-specific differences in adsorption efficiency that may inform clinical decisions regarding dose, timing, and the potential use of additional charcoal administration.
No takes yet. Share an insight, caveat, or question.
Wood et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: